These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 28589387)
21. PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. López-Knowles E; Hernández S; Malats N; Kogevinas M; Lloreta J; Carrato A; Tardón A; Serra C; Real FX Cancer Res; 2006 Aug; 66(15):7401-4. PubMed ID: 16885334 [TBL] [Abstract][Full Text] [Related]
22. FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Bakkar AA; Wallerand H; Radvanyi F; Lahaye JB; Pissard S; Lecerf L; Kouyoumdjian JC; Abbou CC; Pairon JC; Jaurand MC; Thiery JP; Chopin DK; de Medina SG Cancer Res; 2003 Dec; 63(23):8108-12. PubMed ID: 14678961 [TBL] [Abstract][Full Text] [Related]
23. Plasmacytoid variant of urothelial carcinoma: a report of a rare case. Demellawy DE; Ahmed AD; Bora B; Bonin M Pathol Res Pract; 2012 Sep; 208(9):561-4. PubMed ID: 22854197 [TBL] [Abstract][Full Text] [Related]
24. Molecular basis of urinary bladder cancer. Al Hussain TO; Akhtar M Adv Anat Pathol; 2013 Jan; 20(1):53-60. PubMed ID: 23232572 [TBL] [Abstract][Full Text] [Related]
25. [Urothelial carcinoma. Does surgical pathology learn from molecular pathology?]. Hofstädter F Pathologe; 2008 Nov; 29 Suppl 2():145-8. PubMed ID: 18836723 [TBL] [Abstract][Full Text] [Related]
26. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens. Ylagan LR; Humphrey PA Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725 [TBL] [Abstract][Full Text] [Related]
27. Coexistence of papillary and nodular carcinomas in the urinary bladder. Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141 [TBL] [Abstract][Full Text] [Related]
28. The relationship between non-invasive papillary lesions and invasive bladder carcinoma. Brawn PN Cancer; 1984 Aug; 54(4):620-3. PubMed ID: 6744201 [TBL] [Abstract][Full Text] [Related]
29. The Emerging Molecular Landscape of Urothelial Carcinoma. Solomon JP; Hansel DE Surg Pathol Clin; 2016 Sep; 9(3):391-404. PubMed ID: 27523968 [TBL] [Abstract][Full Text] [Related]
30. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226 [TBL] [Abstract][Full Text] [Related]
31. Coexistence of Malakoplakia and Papillary Urothelial Carcinoma of the Urinary Bladder. Lee SL; Teo JK; Lim SK; Salkade HP; Mancer K Int J Surg Pathol; 2015 Oct; 23(7):575-8. PubMed ID: 26194600 [TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma with concurrent urothelial carcinoma of urinary bladder and non-Hodgkin lymphoma. Müller D; Tomasović-Loncarić C; Galeic-Iljubanović D; Heinzl R; Savić I; Marusić P Coll Antropol; 2012 Sep; 36(3):1049-52. PubMed ID: 23213971 [TBL] [Abstract][Full Text] [Related]
33. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases. Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations. Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075 [TBL] [Abstract][Full Text] [Related]
35. Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder. van Oers JM; Adam C; Denzinger S; Stoehr R; Bertz S; Zaak D; Stief C; Hofstaedter F; Zwarthoff EC; van der Kwast TH; Knuechel R; Hartmann A Int J Cancer; 2006 Sep; 119(5):1212-5. PubMed ID: 16570285 [TBL] [Abstract][Full Text] [Related]
36. FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma. Zhou H; He F; Mendelsohn CL; Tang MS; Huang C; Wu XR Sci Rep; 2016 May; 6():25596. PubMed ID: 27157475 [TBL] [Abstract][Full Text] [Related]
37. Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma. Montoya-Cerrillo D; Briski LM; Jorda M; Kryvenko ON Int J Surg Pathol; 2022 May; 30(3):260-264. PubMed ID: 34665053 [No Abstract] [Full Text] [Related]
39. A case of tubulocystic carcinoma simultaneously occurring with clear cell type renal cell carcinoma and micropapillary urothelial carcinoma of bladder. Gönül II; Cakr A; Sözen S; Ataoglu O; Alkibay T South Med J; 2009 Jul; 102(7):754-7. PubMed ID: 19488016 [TBL] [Abstract][Full Text] [Related]